Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR

Fig. 3

Immune cell density according to tumor BRCA1/2 mutation status. The vertical axis indicates cell count/mm2, and the horizontal axis indicates the tumor BRCA1/2 mutation status. The numbers of patients are as follows: positive, N = 12; negative, N = 43. Immune cell density showed no association with tumor BRCA1/2 mutation status

Back to article page